Literature DB >> 22799391

Evidence-based screening, early diagnosis and treatment strategy of cervical cancer for national policy in low- resource countries: example of India.

Upma Saxena1, Catherine Sauvaget, Rengaswamy Sankaranarayanan.   

Abstract

Cervical cancer remains the most frequent cancer in women from the developing world. More than 88% of deaths occur in low-income countries, and it is predicted to climb to 91.5% by 2030. Although Pap-based screening programmes have shown to be effective in reducing the disease burden in high-resource countries, implementation and sustention of cytology-based programmes is quite challenging in low-resource settings. The present paper reviews evidence-based alternatives of screening methods, triaging algorithm, treatment of cervical precancerous lesions, and age-group at screening appropriate for low-income countries. Evidence shows that visual inspection methods using diluted acid acetic or Lugol's iodine, and HPV-DNA testing are more sensitive tests than the Pap-smear screening test. Visual inspection allows an immediate result and, when appropriate, may be immediately followed by cryotherapy, the so called "screen-and-treat" approach, achieved in a single visit, by trained nurses and midwives. Examples of cervical cancer prevention programmes in India and selected low-income countries are given.

Entities:  

Mesh:

Year:  2012        PMID: 22799391     DOI: 10.7314/apjcp.2012.13.4.1699

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  17 in total

1.  An integrative behavior theory derived model to assess factors affecting HPV vaccine acceptance using structural equation modeling.

Authors:  Abraham Degarege; Karl Krupp; Kristopher Fennie; Vijaya Srinivas; Tan Li; Dionne P Stephens; Purnima Madhivanan
Journal:  Vaccine       Date:  2019-01-14       Impact factor: 3.641

Review 2.  Advancing cervical cancer prevention in India: implementation science priorities.

Authors:  Suneeta Krishnan; Emily Madsen; Deborah Porterfield; Beena Varghese
Journal:  Oncologist       Date:  2013-11-11

3.  Knowledge and Attitudes Towards Human Papillomavirus (HPV) Among Academic and Community Physicians in Mangalore, India.

Authors:  Chelsea Canon; Valery Effoe; Veena Shetty; Avinash K Shetty
Journal:  J Cancer Educ       Date:  2017-06       Impact factor: 2.037

Review 4.  Update on prevention and screening of cervical cancer.

Authors:  Shaniqua L McGraw; Jeanne M Ferrante
Journal:  World J Clin Oncol       Date:  2014-10-10

Review 5.  Developing the Evidence Base to Inform Best Practice: A Scoping Study of Breast and Cervical Cancer Reviews in Low- and Middle-Income Countries.

Authors:  Margaret M Demment; Karen Peters; J Andrew Dykens; Ann Dozier; Haq Nawaz; Scott McIntosh; Jennifer S Smith; Angela Sy; Tracy Irwin; Thomas T Fogg; Mahmooda Khaliq; Rachel Blumenfeld; Mehran Massoudi; Timothy De Ver Dye
Journal:  PLoS One       Date:  2015-09-01       Impact factor: 3.240

6.  Alsterpaullone, a Cyclin-Dependent Kinase Inhibitor, Mediated Toxicity in HeLa Cells through Apoptosis-Inducing Effect.

Authors:  Chunying Cui; Yuji Wang; Yaonan Wang; Ming Zhao; Shiqi Peng
Journal:  J Anal Methods Chem       Date:  2013-03-12       Impact factor: 2.193

7.  The Clinical Role of HPV Testing in Primary and Secondary Cervical Cancer Screening.

Authors:  G Hoste; K Vossaert; W A J Poppe
Journal:  Obstet Gynecol Int       Date:  2013-07-01

Review 8.  HPV Vaccination in India: Critical Appraisal.

Authors:  Aruna Nigam; Pikee Saxena; Anita S Acharya; Archana Mishra; Swaraj Batra
Journal:  ISRN Obstet Gynecol       Date:  2014-03-11

9.  The potential harms of primary human papillomavirus screening in over-screened women: a microsimulation study.

Authors:  Steffie K Naber; Inge M C M de Kok; Suzette M Matthijsse; Marjolein van Ballegooijen
Journal:  Cancer Causes Control       Date:  2016-03-12       Impact factor: 2.506

10.  Report from a symposium on catalyzing primary and secondary prevention of cancer in India.

Authors:  Suneeta Krishnan; Preet K Dhillon; Afsan Bhadelia; Anna Schurmann; Partha Basu; Neerja Bhatla; Praveen Birur; Rajeev Colaco; Subhojit Dey; Surbhi Grover; Harmala Gupta; Rakesh Gupta; Vandana Gupta; Megan A Lewis; Ravi Mehrotra; Ann McMikel; Arnab Mukherji; Navami Naik; Laura Nyblade; Sanghamitra Pati; M Radhakrishna Pillai; Preetha Rajaraman; Chalurvarayaswamy Ramesh; G K Rath; Richard Reithinger; Rengaswamy Sankaranarayanan; Jerard Selvam; M S Shanmugam; Krithiga Shridhar; Maqsood Siddiqi; Linda Squiers; Sujha Subramanian; Sandra M Travasso; Yogesh Verma; M Vijayakumar; Bryan J Weiner; K Srinath Reddy; Felicia M Knaul
Journal:  Cancer Causes Control       Date:  2015-09-03       Impact factor: 2.506

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.